...
首页> 外文期刊>Infection and immunity >Toll-Like Receptor 2 Mediates Cellular Activation by the B Subunits of Type II Heat-Labile Enterotoxins
【24h】

Toll-Like Receptor 2 Mediates Cellular Activation by the B Subunits of Type II Heat-Labile Enterotoxins

机译:类似Toll样受体2通过II型不耐热肠毒素的B亚基介导细胞活化

获取原文
           

摘要

The type II heat-labile enterotoxins (LT-IIa and LT-IIb) of Escherichia coli have an AB5 subunit structure similar to that of cholera toxin (CT) and other type I enterotoxins, despite significant differences in the amino acid sequences of their B subunits and different ganglioside receptor specificities. LT-II holotoxins and their nontoxic B subunits display unique properties as immunological adjuvants distinct from those of CT and its B subunits. In contrast to type II holotoxins, the corresponding pentameric B subunits, LT-IIaB and LT-IIbB, stimulated cytokine release in both human and mouse cells dependent upon Toll-like receptor 2 (TLR2). Induction of interleukin-1β (IL-1β), IL-6, IL-8, or tumor necrosis factor alpha in human THP-1 cells by LT-IIaB or LT-IIbB was inhibited by anti-TLR2 but not by anti-TLR4 antibody. Furthermore, transient expression of TLR1 and TLR2 in human embryonic kidney 293 cells resulted in activation of a nuclear factor-κB-dependent luciferase gene in response to LT-IIaB or LT-IIbB. Moreover, peritoneal macrophages from TLR2-deficient mice failed to respond to LT-IIaB or LT-IIbB, in contrast to wild-type or TLR4-deficient cells. These results demonstrate that besides their established binding to gangliosides, the B subunits of type II enterotoxins also interact with TLR2. Although a ganglioside-nonbinding mutant (T34I) of LT-IIaB effectively induced cytokine release, a phenotypically similar point mutation (T13I) in LT-IIbB abrogated cytokine induction, suggesting a variable requirement for gangliosides as coreceptors in TLR2 agonist activity. TLR2-dependent activation of mononuclear cells by type II enterotoxin B subunits appears to be a novel mechanism whereby these molecules may exert their immunomodulatory and adjuvant activities.
机译:大肠埃希菌的II型不耐热肠毒素(LT-IIa和LT-IIb)的AB 5 亚基结构类似于霍乱毒素(CT)和其他I型肠毒素,尽管其B亚基的氨基酸序列存在明显差异,并且神经节苷脂受体的特异性不同。作为免疫佐剂,LT-II全毒素及其无毒的B亚基表现出独特的特性,不同于CT及其B亚基。与II型全毒素相反,依赖于Toll样受体2(TLR2),相应的五聚体B亚基LT-IIaB和LT-IIbB刺激了人和小鼠细胞中的细胞因子释放。 TL-IIaB或LT-IIbB诱导人THP-1细胞中白介素1β(IL-1β),IL-6,IL-8或肿瘤坏死因子α被抗TLR2抑制,但不受抗TLR4抑制抗体。此外,TLR1和TLR2在人类胚胎肾293细胞中的瞬时表达导致响应LT-IIaB或LT-IIbB的核因子-κB依赖的荧光素酶基因的激活。此外,与野生型或TLR4缺陷细胞相比,TLR2缺陷小鼠的腹膜巨噬细胞不能对LT-IIaB或LT-IIbB作出反应。这些结果表明,除了已确定的与神经节苷脂的结合外,II型肠毒素的B亚基还与TLR2相互作用。尽管LT-IIaB的神经节苷脂非结合突变体(T34I)有效地诱导了细胞因子的释放,但LT-IIbB的表型相似点突变(T13I)废除了细胞因子的诱导,这表明神经节苷脂作为TLR2激动剂活性的共受体需要不同的要求。 II型肠毒素B亚基对TLR2依赖性单核细胞的激活似乎是一种新颖的机制,由此这些分子可发挥其免疫调节和佐剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号